Morepen Laboratories' Stock Reaches 52-Week High, Outperforms Sector and Sensex

Morepen Laboratories, a smallcap pharmaceutical company, has been making waves in the stock market with its recent performance. On July 8th, the company's stock price reached a 52-week high of Rs. 60.74, which is a significant milestone for the company. MarketsMOJO, a leading stock market analysis and recommendation platform, has given a 'Buy' call for Morepen Laboratories. This is a positive sign for investors, as it indicates that the company's stock is expected to perform well in the future. In terms of performance, Morepen Laboratories has outperformed the sector by 2.77% and has been on a consecutive gain for the last 2 days. This has resulted in a 8.61% increase in returns for investors in this period. The stock also touched an intraday high of Rs. 60.74, showing a 3.11% increase. Moreover, Morepen Laboratories is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend for the company's stock and suggests that it is in a good position for growth. In comparison to the Sensex, Morepen Laboratories has shown an impressive 1-year performance of 96.13%, while the Sensex has only grown by 22.39%. This further highlights the company's strong performance and potential for growth. With its recent achievements and positive outlook, Morepen Laboratories is definitely a company to watch out for in the pharma industry. Investors can consider adding this smallcap company to their portfolio for potential returns.